Genisphere Adapts 3DNA® Dendrimer Technology to Lateral Flow Point-of-Care Assays
08:00 EDT 17 Jul 2012 | Businesswire
This article has expired, however you can still
download the PDF.
Preview:
Genisphere has adapted its pioneering 3DNA
Dendrimer Signal Amplification technology for Lateral Flow (LF)
Point-of-Care (POC) assays, providing improved sensitivity and enabling
a broad new array of POC tests. LF assays represe...
Other Sources for this Article
Genisphere
Jim Kadushin, 215-996-3027
Jim_Kadushin@genisphere.com
or
Chempetitive
Group
Ken Li, 312-997-2436 x 109
kli@chempetitive.com
More From BioPortfolio on "Genisphere Adapts 3DNA® Dendrimer Technology to Lateral Flow Point-of-Care Assays"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
